Swiss Face Difficult Pharma Negotiations With Mercosur

(MENAFN- Swissinfo) Work still needs to be done on pharmaceutical products as part of the free trade agreement signed with Mercosur, said Swiss Economics Minister Guy Parmelin. This content was published on July 4, 2025 - 13:46 1 minute Keystone-SDA

• Français fr Mercosur: négociations“difficiles” sur la pharma, dit Guy Parmelin Original Read more: Mercosur: négociations“difficiles” sur la pharma, dit Guy Parmeli

+Get the most important news from Switzerland in your inbox

However, Parmelin added that the outcome of the negotiations was very good.

“The negotiations were difficult right up to the end, particularly on the intellectual property of pharmaceutical products,” said Parmelin on arriving at Zurich airport.

He was returning from a visit to Brazil and Argentina, during which the free trade agreement between EFTA and Mercosur was concluded.

“Brazil has stalled on this point,” Parmelin explained. Negotiations are still possible, however, he added. Parmelin nevertheless felt that Switzerland had generally“achieved a very good result”, including access to the Mercosur market.

Translated from French by DeepL/mga

More More Switzerland and EFTA sign trade deal with Mercosur

This content was published on Jul 2, 2025 Switzerland and EFTA sign a free trade deal with Mercosur, offering customs savings up to CHF160 million.

Read more: Switzerland and EFTA sign trade deal with Mercosu

MENAFN04072025000210011054ID1109761469